Effect of cellular and receptor activation on the extent of integrin α IIbβ 3 internalization

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2404-2410

  Schober, J M ^a   lam, S C T ^a   Wencel Drake, J D ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Integrin IIb 3; Internalization; Platelet activation

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE; FIBRINOGEN RECEPTOR; THROMBIN RECEPTOR;

ARTICLE; CYTOSKELETON; DOWN REGULATION; DRUG EFFECT; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; METABOLISM; PHYSIOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESIVENESS;

ACTINS; ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CYTOSKELETON; DOWN-REGULATION; ENDOCYTOSIS; FLOW CYTOMETRY; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, THROMBIN;

EID: 4444284674     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00417.x     Document Type: Article

References (37)

1. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood 1998; 91: 2645-57.
2. Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-43.
3. Peerschke El, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correla tion between fibrinogen binding to human platelets and platelet aggreg- ability. Blood 1980; 55: 841-7.
4. Wencel-Drake JD, Boudignon-Proudhon C, Dieter MG, Criss AB, Parise LV. Internalization of bound fibrinogen modulates platelet ag gregation. Blood 1996; 87: 602-12.
5. Wencel-Drake JD, Frelinger AL III, Dieter MG, Lam SC. Arg-Gly-Asp- dependent occupancy of GPIIb/IIIa by applaggin: evidence for internalization and cycling of a platelet integrin. Blood 1993; 81: 62-9.
6. Fox JE, Shattil SJ, Kinlough-Rathbone RL, Richardson M, Packham MA. Sanan DA. The platelet cytoskeleton stabilizes the interaction between alphallbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 1996; 271: 7004-11.
7. Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rudiger S, Taubitz W, Fischer J, Muller I, Meier D, Patscheke K, Schomig A. Incomplete inhibition of platelet aggregation and glycoprotein Ilb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein Ilb-Illa receptors. Thromb Haemost 2000; 83: 915-22.
8. Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA, Smith JW. The amino-terminal one-third of alpha lib defines the ligand recognition specificity of integrin alpha lib beta 3. J Biol Chem 1996; 271: 2033-9.
9. Pidard D, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein Ilb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-6.
10. Frelinger AL IIIXP, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin alpha lib beta 3 (glycoprotein Ilb-IIIa) alter receptor affinity, specificity, and function. J Biol Chem 1991; 266: 17106-11.
11. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein lib·Ilia complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
12. McGowan EB, Detwiler TC. Characterization of the thrombin-induced desensitization of platelet activation by thrombin. Thromb Res 1983; 31: 297-304.
13. Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase. Mol Pharmacol 1986; 29: 1-6.
14. Peerschke EL Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation. J Lab Clin Med 1985; 106: 111-22.
15. Baurand A, Eckly A, Bari N, Leon C, Hechler B, Cazenave JP, Gachet C. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 2000; 84: 484-91
16. O'Toole TE, Katagiri Y,Faull RJ, Peter K, Tamura R, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-59.
17. Savage B, Marzec UM, Chao BH, Harker LA, Maraganore JM, Ruggeri ZM. Binding of the snake venom-derived proteins applaggin and echi statin to the arginine-glycine-aspartic acid recognition site(s) on platelet glyco protein Ilb·IIIa complex inhibits receptor function. J Biol Chem 1990; 265: 11766-72.
18. Marcinkiewicz C, Vijay-Kumar S, McLane MA, Niewiarowski S. Significance of RGD loop and C-terminal domain of echistatin for recognition of alphallb beta3 and alpha(v)beta3 integrins and expression of ligand-induced binding site. Blood 1997; 90: 1565-75.
19. Ginsberg MH, Frelinger AL, Lam SC, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein Ilb-IIIa with conforma tion-specific monoclonal antibodies. Blood 1990; 76: 2017-23.
20. Fox JE, Phillips DR. Inhibition of actin polymerization in blood platelets by cytochalasins. Nature 1981; 292: 650-2.
21. Jennings LK, Dockter ME, Wall CD, Fox CF, Kennedy DM. Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood 1989; 74: 2674-80.
22. Huang EM, Detwiler TC. Characteristics of the synergistic actions of platelet agonists. Blood 1981; 57: 685-91.
23. Jennings LK, Fox JE, Edwards HH, Phillips DR. Changes in the cytoskeletal structure of human platelets following thrombin activation. J Biol Chem 1981; 256: 6927-32.
24. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein Ilb-IIIa complex. Blood 1988; 71: 831-4-3.
25. Plow EF, Ginsberg MH. Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. Prog Hemost Thromb 1989; 9: 117-56.
26. Wang XF, Liu F, Morris SA, Carroll RC. Synergistic outside-in regula tion of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization. Thromb Res 2001; 104: 239-47.
27. Carroll RC, Wang XF, Lanza F, Steiner B, Kouns WC. Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2. Thromb Res 1997; 88: 109-25.
28. Gan ZR, Gould RJ, Jacobs JW, Friedman PA, Polokoff MA. Echistatin: a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J Biol Chem 1988; 263: 19827-32.
29. Du XP, Plow EF, Frelinger AL III, O'Toole TE, Loftus JC, Ginsberg MH. Ligands 'activate' integrin alpha lib beta 3 (platelet GPIIb-IIIa). Cell 1991; 65: 409-16.
30. Marcinkiewicz C, Rosenthal LA, Mosser DM, Kunicki TJ, Niewiarowski S. Immunological characterization of eristostatin and echistatin binding sites on alpha lib beta 3 and alpha V beta 3 integrins. Biochem J 1996; 317: 817-25.
31. Juliano D, Wang Y, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit. Exp Cell Res 1996; 225: 132-42.
32. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem 1999; 274: 28071-4.
33. Vinogradova O, Velyvis A, Velyviene A, Hu B, Haas T, Plow E, Qin J. A Structural mechanism of integrin alpha(IIb)beta(3) 'inside-out' activa tion as regulated by its cytoplasmic face. Cell 2002; 110: 587.
34. Leitinger B, McDowall A, Stanley P, Hogg N. The regulation of integrin function by Ca(2+). Biochim Biophys Acta 2000; 1498: 91-8.
35. 2+. J Biol Chem 1995; 270: 26270-7.
36. Byzova TV, Plow EF. Activation of alpha Vbeta3 on vascular cells controls recognition of prothrombin. J Cell Biol 1998; 143: 2081-92.
37. 2+- complexed crystal structures. J Cell Biol 1998; 143: 1523-34